How to safely and smoothly resume trials after the COVID-19 outbreak
- PMID: 33110514
- PMCID: PMC7535132
- DOI: 10.7189/jogh.10.020310
How to safely and smoothly resume trials after the COVID-19 outbreak
Conflict of interest statement
Competing interests: The authors declare no conflicts of interest and completed the ICMJE Unified Competing Interest form (available upon request from the corresponding author), and declare no conflicts of interest.
Figures
References
-
- Beijing Municipal Health Commission. Orderly Promoting Daily Medical Services for People’s Demands. Available: http://wjw.beijing.gov.cn/xwzx_20031/wnxw/202003/t20200321_ 1723839.html. Accessed: 10 March 2020.
-
- General Office of the People’s Government of Beijing Municipality. Notice of the General Office of the People’s government of Beijing Municipality on issuing the measures to prevent and control the epidemic situation and ensure the enterprises to return to work in order. Available: http://www.beijing.gov.cn/zhengce/zhengcefagui/202003/ t20200315_1706857.... Accessed: 16 March 2020.
-
- Integrated Addendum to ICH E6(R1): Guideline for Good Clinical Practice (R2). International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). Available: https://www.ich.org/fileadmin/Public_Web_Site/ICH_ Products/ Guidelines/.... Accessed: 9 November 2016.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical